{"nct_id":"NCT04626479","title":"Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2020-12-16","start_date_type":"ACTUAL","primary_completion_date":"2026-05-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-05-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}